Protection of midbrain dopaminergic neurons by the end‐product of purine metabolism uric acid: potentiation by low‐level depolarization
Open Access
- 14 April 2009
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 109 (4), 1118-1128
- https://doi.org/10.1111/j.1471-4159.2009.06040.x
Abstract
High plasma levels of the end product of purine metabolism uric acid (UA) predict a reduced risk of developing Parkinson’s disease suggesting that UA may operate as a protective factor for midbrain dopaminergic neurons. Consistent with this view, UA exerted partial but long‐term protection in a culture model in which these neurons die spontaneously. The rescued neurons were functional as they accumulated dopamine, efficiently. The use of the fluorescent probe dihydrorhodamine‐123 revealed that UA operated by an antioxidant mechanism. The iron chelating agent desferrioxamine, the H2O2 scavenger enzyme catalase and the inhibitor of lipid peroxidation Trolox mimicked the effects of UA, suggesting that UA neutralized reactive oxygen species produced via a Fenton‐type chemical reaction. UA was, however, not significantly accumulated into neurons, which indicates that the antioxidant effect occurred probably extracellularly. Structure – activity relationships among purine derivatives revealed that the antioxidant properties of UA resulted from the presence of a 8‐one substituent in its chemical structure. Of interest, the stimulation of L‐type Ca2+ channels by high K+‐induced depolarization and the ensuing activation of extracellular signal‐regulated kinases 1/2 strongly improved the neuroprotective effect of UA whereas the depolarizing signal alone had no effect. In summary, our data indicate that UA may interfere directly with the disease’s pathomechanism.Keywords
This publication has 39 references indexed in Scilit:
- Modelling Parkinson‐like neurodegeneration via osmotic minipump delivery of MPTP and probenecidJournal of Neurochemistry, 2008
- The influence of uric acid treatments on liver glutathione system prevent oxidative damages in experimental autoimmune encephalomyelitis miceNeuroscience Letters, 2008
- Gout and risk of Parkinson diseaseNeurology, 2007
- Parkinson's Disease: Mechanisms and ModelsNeuron, 2003
- Glutathione, iron and Parkinson’s diseaseBiochemical Pharmacology, 2002
- Generation of Tyrosine Hydroxylase-Producing Neurons from Precursors of the Embryonic and Adult ForebrainJournal of Neuroscience, 1999
- Uric acid is reduced in the substantia nigra in parkinson's disease: Effect on dopamine oxidationBrain Research Bulletin, 1994
- The Pecking Order of Free Radicals and Antioxidants: Lipid Peroxidation, α-Tocopherol, and AscorbateArchives of Biochemistry and Biophysics, 1993
- Parkinson's disease: pathophysiologyThe Lancet, 1991
- Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.Proceedings of the National Academy of Sciences of the United States of America, 1981